Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
2
×
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
2
×
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
2
×
wisconsin blog main
wisconsin top stories
accent therapeutics
acute myeloid leukemia
aducanumab
alzheimer's disease
amblyotech
american society of clinical oncology
applied therapeutics
asklepios biopharmaceutical
bioeurope
What
bio
fda
2
×
roundup
2
×
activity
ahead
approvals
asco
biogen
branded
choices
clamped
commissioner
consumers
costly
counterweight
covid
delays
developing
drugs
economic
elevatebio
fast
generic
graft
including
ipo
isn’t
lot
medications
medicines
new
oric’s
rises
showing
spread
supposed
tenure
testing
work
Language
unset
Current search:
roundup
×
cancer
×
fda
×
" san francisco blog main "
×
" venture capital "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More